Our brands

Herti

Herti is a HER2-targeted monoclonal antibody indicated for the treatment of HER2-positive breast and gastric cancers. It binds to the HER2 receptor, inhibiting downstream signaling pathways that drive cancer cell growth and survival.

Herti
  • Herti 150 Mg Injection

    Trastuzumab 150 Mg
  • Herti 440 Mg Injection

    Trastuzumab 440 Mg

subscribe

Keep yourself updated with our new product information and much more.

Copyright © All Rights Reserved by Hetero Healthcare Limited